10x Genomics, Inc.

Historical 13F Holders

Symbol
TXG
CUSIP
88025U109
All holders as of
Q1 2025
Type
Equity
Class
CL A COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 281 114 M $993 M
2024 Q4 283 105 M $1.50 B
2024 Q3 273 105 M $2.37 B
2024 Q2 271 111 M $2.16 B
2024 Q1 302 114 M $4.27 B
2023 Q4 289 102 M $5.73 B
2023 Q3 271 91.6 M $3.78 B
2023 Q2 288 90.4 M $5.05 B
2023 Q1 270 91.2 M $5.08 B
2022 Q4 289 89.0 M $3.24 B
2022 Q3 242 86.1 M $2.45 B
2022 Q2 261 86.1 M $3.91 B
2022 Q1 333 82.8 M $6.30 B
2021 Q4 382 80.0 M $11.9 B
2021 Q3 342 78.8 M $11.5 B
2021 Q2 366 78.0 M $15.3 B
2021 Q1 339 70.5 M $12.8 B
2020 Q4 329 66.6 M $9.43 B
2020 Q3 232 69.1 M $8.55 B
2020 Q2 160 61.0 M $5.45 B
2020 Q1 114 39.3 M $2.45 B
2019 Q4 93 30.9 M $2.36 B
2019 Q3 94 22.4 M $1.13 B